Biggest changeCash Flow Activity The following table presents the cash flow activity for the period indicated: As of December 31, (in thousands) 2024 2023 Cash and cash equivalents, beginning of year $ 3,913 $ 926 Cash provided by operating activities 7,521 4,405 Cash used in investing activities (1,898 ) (1,281 ) Cash provided by (used in) financing activities 3,105 (137 ) Net change in cash and cash equivalents 8,728 2,987 Cash and cash equivalents, end of year $ 12,641 $ 3,913 Operating Activities Cash provided by operating activities was $7,521 in 2024 compared to $4,405 in 2023, an increase of $3,116 primarily due to the following: • Net income increased $4,147 from $3,489 in 2023 to $7,636 in 2024; and • Deferred income tax provision increased $996 from ($784) in 2023 to $212 in 2024.
Biggest changeCash Flow Activity The following table presents the cash flow activity for the period indicated: As of December 31, (in thousands) 2025 2024 Cash and cash equivalents, beginning of year $ 12,641 $ 3,913 Cash provided by operating activities 10,659 7,521 Cash used in investing activities (2,551 ) (1,898 ) Cash provided by financing activities 142 3,105 Net change in cash and cash equivalents 8,250 8,728 Cash and cash equivalents, end of year $ 20,891 $ 12,641 Operating Activities Cash provided by operating activities was $10,659 in 2025 compared to $7,521 in 2024, an increase of $3,138 primarily due to the following: • Higher net income; • Higher non-cash adjustments, including: ◦ Stock-based compensation expense, which increased $445 from $636 in 2024 to $1,081 in 2025; ◦ Deferred income tax provision, which decreased $1,268 from $212 in 2024 to $1,480 in 2025; • Working capital movements, including: ◦ Accounts receivable, which decreased $186 in 2025 compared to an increase of $2,040 in 2024, reflecting shorter customer payment cycles; ◦ Inventories, net, which increased $164 in 2025 compared to $625 in 2024; ◦ Prepaid expenses and other assets, which increased $1,156 in 2025 compared to $165 in 2024, primarily due to higher income taxes receivable; and ◦ Accounts payable, accrued compensation and other expenses, and other liabilities, which increased $328 in 2025 compared to $889 in 2024, primarily due to the timing of goods received and services performed prior to period end and reflects normal fluctuations in operating activity.
The decrease in backlog from December 31, 2023 reflects the nature of a program centric business model, which can materially affect backlog based on the timing and size of these orders. The backlog of unfilled orders includes amounts based on signed contracts and purchase orders, which are likely to be fulfilled substantially within the next 12 to 24 months.
The increase in backlog from December 31, 2024 reflects the nature of a program centric business model, which can materially affect backlog based on the timing and size of these orders. The backlog of unfilled orders includes amounts based on signed contracts and purchase orders, which are likely to be fulfilled substantially within the next 12 to 24 months.
For a discussion of the year ended December 31, 2023 compared to the year ended December 31, 2022, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 25, 2024, which is available free of charge on the SEC's website at https://www.sec.gov and on our website at ir.mtronpti.com.
For a discussion of the year ended December 31, 2024 compared to the year ended December 31, 2023, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 27, 2025, which is available free of charge on the SEC's website at https://www.sec.gov and on our website at ir.mtron.com.
Financing Activities Cash provided by (used in) financing activities was $3,105 in 2024 compared to ($137) in 2023, an increase of $3,242 primarily due to the exercise of stock options awarded in December 2023. 19 Table of Contents Capital Resources We believe that existing cash and cash equivalents, marketable securities and cash generated from operations will provide sufficient liquidity to meet our ongoing working capital and capital expenditure requirements for the next 12 months from the date of this filing and for the foreseeable future.
Financing Activities Cash provided by financing activities was $142 in 2025 compared to $3,105 in 2024, a decrease of $2,963 primarily due to lower exercises of stock options awarded in December 2023. 19 Table of Contents Capital Resources We believe that existing cash and cash equivalents, marketable securities and cash generated from operations will provide sufficient liquidity to meet our ongoing working capital and capital expenditure requirements for the next 12 months from the date of this filing and for the foreseeable future.
Our Board has adhered to a practice of not paying cash dividends. This policy takes into account our long-term growth objectives, including our anticipated investments for organic growth, potential acquisitions or other strategic ventures and stockholders' desire for capital appreciation of their holdings.
The Company’s management continues to strive for profitability both internally and through acquisition. Our Board has adhered to a practice of not paying cash dividends. This policy takes into account our long-term growth objectives, including our anticipated investments for organic growth, potential acquisitions or other strategic ventures and stockholders' desire for capital appreciation of their holdings.
Investing Activities Cash used in investing activities was $1,898 in 2024 compared to $1,281 in 2023, an increase of $617 primarily due to the purchase of equipment to support growth and next generation product development.
Investing Activities Cash used in investing activities was $2,551 in 2025 compared to $1,898 in 2024, an increase of $653 primarily due to the purchase of equipment to support growth and next generation product development.
Our working capital metrics were as follows: As of December 31, (in thousands) 2024 2023 Current assets $ 29,752 $ 18,187 Less: Current liabilities 5,216 4,384 Working capital $ 24,536 $ 13,803 Current ratio 5.7 4.1 Management continues to focus on efficiently managing working capital requirements to match operating activity levels and will seek to deploy the Company’s working capital where it will generate the greatest returns.
Our working capital metrics were as follows: As of December 31, (in thousands) 2025 2024 Current assets $ 61,217 $ 29,752 Less: Current liabilities 4,891 5,216 Working capital $ 56,326 $ 24,536 Current ratio 12.5 5.7 Management continues to focus on efficiently managing working capital requirements to match operating activity levels and will seek to deploy the Company’s working capital where it will generate the greatest returns.
We expect to fill the vast majority of our order backlog as of December 31, 2024 during 2025 and 2026, but cannot provide assurances as to what portion of the order backlog will be fulfilled in any given year. 17 Table of Contents Non-GAAP Financial Measures To supplement our Consolidated Financial Statements presented on a GAAP basis, the Company presents its financial condition and results of operations in the way it believes will be most meaningful and representative of its business results.
We expect to fill the vast majority of our order backlog as of December 31, 2025 during 2026 and 2027, but cannot provide assurances as to what portion of the order backlog will be fulfilled in any given year. 17 Table of Contents Non-GAAP Financial Measures To supplement our Consolidated Financial Statements presented on a U.S.
As of December 31, 2024 and 2023, Cash and cash equivalents were $12,641 and $3,913, respectively.
As of December 31, 2025 and 2024, Cash and cash equivalents were $20,891 and $12,641, respectively.
Trends and Uncertainties We are not aware of any material trends or uncertainties, other than the global economic conditions affecting our industry generally, that may reasonably be expected to have a material impact, favorable or unfavorable, on our revenues or income other than those listed in Part I, Item 1A, Risk Factors, of this Annual Report on Form 10-K. 16 Table of Contents Results of Operations The following table presents our Consolidated Statements of Operations for the periods indicated: Year Ended December 31, (in thousands) 2024 2023 $ Change % Change Revenues $ 49,012 $ 41,168 $ 7,844 19.1 % Costs and expenses: Manufacturing cost of sales 26,372 24,402 1,970 8.1 % Engineering, selling and administrative 13,246 12,467 779 6.2 % Total costs and expenses 39,618 36,869 2,749 7.5 % Operating income 9,394 4,299 5,095 118.5 % Other income: Interest income, net 243 7 236 3,371.4 % Other income, net 138 94 44 46.8 % Total other income, net 381 101 280 277.2 % Income before income taxes 9,775 4,400 5,375 122.2 % Income tax expense 2,139 911 1,228 134.8 % Net income $ 7,636 $ 3,489 $ 4,147 118.9 % 2024 compared to 2023 Total Revenues Total revenues increased $7,844, or 19.1%, from $41,168 in 2023 to $49,012 in 2024 primarily due to strong defense program product and solution shipments.
Trends and Uncertainties We are not aware of any material trends or uncertainties, other than the global economic conditions affecting our industry generally, that may reasonably be expected to have a material impact, favorable or unfavorable, on our revenues or income other than those listed in Part I, Item 1A, Risk Factors, of this Annual Report on Form 10-K. 16 Table of Contents Results of Operations The following table presents our Consolidated Statements of Operations for the periods indicated: Year Ended December 31, (in thousands) 2025 2024 $ Change % Change Revenues $ 54,417 $ 49,012 $ 5,405 11.0 % Costs and expenses: Manufacturing cost of sales 30,269 26,372 3,897 14.8 % Engineering, selling and administrative 13,857 13,246 611 4.6 % Total costs and expenses 44,126 39,618 4,508 11.4 % Operating income 10,291 9,394 897 9.5 % Other income: Interest income, net 539 243 296 121.8 % Other income, net 124 138 (14 ) -10.1 % Total other income, net 663 381 282 74.0 % Income before income taxes 10,954 9,775 1,179 12.1 % Income tax expense 2,507 2,139 368 17.2 % Net income $ 8,447 $ 7,636 $ 811 10.6 % 2025 compared to 2024 Total Revenues Total revenues increased $5,405, or 11.0%, from $49,012 in 2024 to $54,417 in 2025 primarily due to strong defense program product and solution shipments, as well as an increase in shipments in the avionics and industrials sectors.
Reconciliation of GAAP Income Before Income Taxes to EBITDA and Non-GAAP Adjusted EBITDA The following table presents a reconciliation of income before income taxes to Adjusted EBITDA, a non-GAAP measure: Three Months Ended December 31, Year Ended December 31, (in thousands, except share data) 2024 2023 2024 2023 Income before income taxes $ 2,758 $ 53 $ 9,775 $ 4,400 Adjustments: Interest income, net (104 ) (13 ) (243 ) (7 ) Depreciation 251 220 968 797 Amortization — 13 5 53 Total adjustments 147 220 730 843 EBITDA 2,905 273 10,505 5,243 Non-cash stock compensation 151 2,124 636 2,421 Excess Separation costs — — — 28 Adjusted EBITDA $ 3,056 $ 2,397 $ 11,141 $ 7,692 Three months ended December 31, 2024 compared to three months ended December 31, 2023 Adjusted EBITDA increased $659 from $2,397 for the three months ended December 31, 2023 to $3,056 for the three months ended December 31, 2024.
Reconciliation of GAAP Income Before Income Taxes to EBITDA and Non-GAAP Adjusted EBITDA The following table presents a reconciliation of income before income taxes to Adjusted EBITDA, a non-GAAP measure: Three Months Ended December 31, Year Ended December 31, (in thousands, except share data) 2025 2024 2025 2024 Income before income taxes $ 4,082 $ 2,758 $ 10,954 $ 9,775 Adjustments: Interest income, net (161 ) (104 ) (539 ) (243 ) Depreciation 286 251 1,086 968 Amortization — — — 5 Total adjustments 125 147 547 730 EBITDA 4,207 2,905 11,501 10,505 Non-cash stock compensation 278 151 1,081 636 Adjusted EBITDA $ 4,485 $ 3,056 $ 12,582 $ 11,141 Three months ended December 31, 2025 compared to three months ended December 31, 2024 Adjusted EBITDA increased $1,429 from $3,056 for the three months ended December 31, 2024 to $4,485 for the three months ended December 31, 2025.
Contractual Obligations The following table summarizes contractual obligations, in total, and by remaining maturity: Payments due by Period (in thousands) Total Payments 2025 Leases $ 10 $ 10 Revolving credit line — — Total $ 10 $ 10 Leases Leases represent the future minimum lease payments under our operating leases.
Contractual Obligations The following table summarizes contractual obligations, in total, and by remaining maturity: Payments due by Period (in thousands) Total Payments 2026 2027 2028 2029 2030 Leases $ 256 $ 74 $ 74 $ 48 $ 48 $ 12 Revolving credit facility — — — — — — Delayed draw facility — — — — — — Total $ 256 $ 74 $ 74 $ 48 $ 48 $ 12 Leases Leases represent the future minimum lease payments under our operating leases.
The presentation of this additional information is not meant to be considered in isolation or as a substitute for net earnings or diluted earnings per share prepared in accordance with GAAP.
The non-GAAP financial measures the Company presents are listed below and may not be comparable to similarly-named measures reported by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net earnings or diluted earnings per share prepared in accordance with U.S. GAAP.
Total Other Income, Net Total other income, net increased $280, or 277.2%, from $101 in 2023 to $381 in 2024 primarily due to a $236 increase in Interest income, net from $7 in 2023 to $243 in 2024 driven by higher interest income earned related to an increase in balances invested in money market mutual funds.
Total Other Income, Net Total other income, net increased $282, or 74.0%, from $381 in 2024 to $663 in 2025 primarily due to a $296 increase in Interest income, net from $243 in 2024 to $539 in 2025 driven by higher average balances invested in money market mutual funds.
Income Tax Expense Income tax expense increased $1,228, or 134.8%, from $911 in 2023 to $2,139 in 2024 primarily due to the increase in Income before income taxes driven by the increase in revenues discussed above. Backlog As of December 31, 2024, our order backlog was $47,239, a decrease of $592, or 1.2%, from $47,831 as of December 31, 2023.
Income Tax Expense Income tax expense increased $368, or 17.2%, from $2,139 in 2024 to $2,507 in 2025 primarily due to the increase in Income before income taxes discussed above. Backlog As of December 31, 2025, our order backlog was $76,425, an increase of $29,186, or 61.8%, from $47,239 as of December 31, 2024.
No cash dividends are expected to be paid for the foreseeable future. 20 Table of Contents Critical Accounting Estimates Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP").
See Note 7 – Revolving Credit Agreement to the Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data of this Report for details of the Credit Agreement. 20 Table of Contents Critical Accounting Estimates Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP").
Total Costs and Expenses Total costs and expenses increased $2,749, or 7.5%, from $36,869 in 2023 to $39,618 in 2024 primarily due to: • a $1,970, or 8.1%, increase in Manufacturing cost of sales from $24,402 in 2023 to $26,372 in 2024 driven by higher revenues partially offset by manufacturing efficiencies and sales of higher margin products; and • a $779, or 6.2%, increase in Engineering, selling and administrative from $12,467 in 2023 to $13,246 in 2024 driven by increased investment in research and development, increased sales commissions consistent with the growth in revenues, and an increase in administrative and corporate expenses to support the growth in revenues.
Total Costs and Expenses Total costs and expenses increased $4,508, or 11.4%, from $39,618 in 2024 to $44,126 in 2025 primarily due to: • a $3,897, or 14.8%, increase in Manufacturing cost of sales from $26,372 in 2024 to $30,269 in 2025 driven by the increase in production of several new products, which result in higher initial manufacturing costs, as well as the impact of tariffs; and • a $611, or 4.6%, increase in Engineering, selling and administrative from $13,246 in 2024 to $13,857 in 2025 driven by continued investment in research and development; higher sales commissions consistent with the growth in revenues; higher stock-based compensation; higher sales and marketing costs; and an increase in administrative and corporate expenses consistent with the overall growth in the business.
The increase was primarily due to improved gross margins and continued containment of expenses, a higher margin product mix, and a decrease in non-cash stock compensation. 18 Table of Contents Liquidity and Capital Resources Overview Liquidity refers to our ability to access sufficient sources of cash to meet the requirements of our operating, investing and financing activities.
Adjusted EBITDA in 2024 included bonus expense of approximately 3.0% of revenues, which was not incurred in 2025. 18 Table of Contents Liquidity and Capital Resources Overview Liquidity refers to our ability to access sufficient sources of cash to meet the requirements of our operating, investing and financing activities.
Gross Margin Gross margin (Revenues less Manufacturing cost of sales as a percentage of Revenues) increased 550 basis points from 40.7% in 2023 to 46.2% in 2024 reflecting higher revenues, improved manufacturing efficiencies, and a higher margin product mix.
The Company's total costs and expenses for 2024 included bonus expense of approximately $1.5 million, or 3.0% of revenues, which was not incurred in 2025. Gross Margin Gross margin (Revenues less Manufacturing cost of sales as a percentage of Revenues) decreased 180 basis points from 46.2% in 2024 to 44.4% in 2025 reflecting product mix and higher tariff-related costs.
Some of the measurements the Company uses are "Non-GAAP financial measures" under SEC rules and regulations. The non-GAAP financial measures the Company presents are listed below and may not be comparable to similarly-named measures reported by other companies.
GAAP basis, the Company presents its financial condition and results of operations in the way it believes will be most meaningful and representative of its business results. Some of the measurements the Company uses are "Non-GAAP financial measures" under SEC rules and regulations.
The increase was primarily due to improved gross margins, continued containment of expenses, a higher margin product mix, and decrease in non-cash stock compensation. Year ended 2024 compared to Year ended 2023 Adjusted EBITDA increased $3,449 from $7,692 in 2023 to $11,141 in 2024.
The increase was primarily due to higher revenues and lower engineering, selling and administrative expenses partially offset by lower gross margin discussed above. Year ended 2025 compared to Year ended 2024 Adjusted EBITDA increased $1,441 from $11,141 in 2024 to $12,582 in 2025.
The Loan Agreement has a maturity date of June 15, 2025 and contains certain financial covenants based on the following criteria: (a) Minimum Fixed Charge Coverage Ratio; (b) Minimum Current Ratio; and (c) Minimum Tangible Net Worth (each as defined in the Loan Agreement).
The Credit Agreement also imposes certain financial covenants based on the following criteria: (a) Leverage Ratio and (b) Fixed Charge Coverage Ratio (each as defined in the Credit Agreement). All loans pursuant to the Credit Agreement are secured by a first-priority lien on substantially all of the personal property of the Company.